Advertisement

Postoperative Care After Bariatric Surgery

  • Fredric M. Pieracci
  • Alfons Pomp
  • Philip S. Barie

Abstract

Bariatric surgery is now commonplace throughout the developed world because of both the obesity pandemic and a substantial body of literature documenting the safety and efficacy of these procedures for the treatment of morbid obesity.

Keywords

Bariatric Surgery Obese Patient Gastric Bypass Continuous Positive Airway Pressure Anastomotic Leak 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg. 2003;13:329–330.PubMedCrossRefGoogle Scholar
  2. 2.
    Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–2693.PubMedCrossRefGoogle Scholar
  3. 3.
    Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–1737.PubMedCrossRefGoogle Scholar
  4. 4.
    Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416–423.PubMedCrossRefGoogle Scholar
  5. 5.
    Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195–1200.PubMedCrossRefGoogle Scholar
  6. 6.
    Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–1529.PubMedCrossRefGoogle Scholar
  7. 7.
    Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA. 2004;291:2847–2850.PubMedCrossRefGoogle Scholar
  8. 8.
    Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293:1861–1867.PubMedCrossRefGoogle Scholar
  9. 9.
    Colditz GA. Economic costs of obesity and inactivity. Med Sci Sports Exerc. 1999;31:S663–S667.PubMedCrossRefGoogle Scholar
  10. 10.
    NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 1991;115:956–961.Google Scholar
  11. 11.
    Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294:1909–1917.PubMedCrossRefGoogle Scholar
  12. 12.
    Steinbrook R. Surgery for severe obesity. N Engl J Med. 2004;350:1075–1079.PubMedCrossRefGoogle Scholar
  13. 13.
    Davis MM, Slish K, Chao C, Cabana MD. National trends in bariatric surgery, 1996–2002. Arch Surg. 2006;141:71–74.PubMedCrossRefGoogle Scholar
  14. 14.
    Nasraway SA Jr, Albert M, Donnelly AM, et al. Morbid obesity is an independent determinant of death among surgical critically ill patients. Crit Care Med. 2006;34:964–970.PubMedCrossRefGoogle Scholar
  15. 15.
    Nguyen NT, Goldman C, Rosenquist CJ, et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg. 2001;234:279–289.PubMedCrossRefGoogle Scholar
  16. 16.
    Helling TS, Willoughby TL, Maxfield DM, Ryan P. Determinants of the need for intensive care and prolonged mechanical ventilation in patients undergoing bariatric surgery. Obes Surg. 2004;14:1036–1041.PubMedCrossRefGoogle Scholar
  17. 17.
    Yeats M, Wedergren S, Fox N, Thompson JS. The use and modification of clinical pathways to achieve specific outcomes in bariatric surgery. Am Surg. 2005;71:152–154.PubMedGoogle Scholar
  18. 18.
    Cendan JC, Abu-aouf D, Gabrielli A, et al. Utilization of intensive care resources in bariatric surgery. Obes Surg. 2005;15:1247–1251.PubMedCrossRefGoogle Scholar
  19. 19.
    Nguyen NT, Silver M, Robinson M, et al. Result of a national audit of bariatric surgery performed at academic centers: a 2004 University HealthSystem Consortium Benchmarking Project. Arch Surg. 2006;141:445–449.PubMedCrossRefGoogle Scholar
  20. 20.
    Flum DR, Salem L, Elrod JA, et al. Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA. 2005;294:1903–1908.PubMedCrossRefGoogle Scholar
  21. 21.
    Zingmond DS, McGory ML, Ko CY. Hospitalization before and after gastric bypass surgery. JAMA. 2005;294:1918–1924.PubMedCrossRefGoogle Scholar
  22. 22.
    Cottam DR, Schaefer PA, Fahmy D, et al. The effect of obesity on neutrophil Fc receptors and adhesion molecules (CD16, CD11b, CD622L). Obes Surg. 2001;12:230–235.CrossRefGoogle Scholar
  23. 23.
    Juhan-Vague MCA. Regulation in fibrinolysis in the development of atherothrombosis: role of adipose tissue. Thromb Haemost. 1999;82:832–836.PubMedGoogle Scholar
  24. 24.
    Beuther DA, Weiss ST, Sutherland ER. Obesity and asthma. Am J Respir Crit Care Med. 2006;174:112–119.PubMedCrossRefGoogle Scholar
  25. 25.
    Ray CS, Sue DY, Bray G, et al. Effects of obesity on respiratory function. Am Rev Respir Dis. 1983;128:501–506.PubMedGoogle Scholar
  26. 26.
    Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007;175:661–666.PubMedCrossRefGoogle Scholar
  27. 27.
    Spivak H, Hewitt MF, Onn A, Half EE. Weight loss and improvement of obesity-related illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedure. Am J Surg. 2005;189:27–32.PubMedCrossRefGoogle Scholar
  28. 28.
    Gibson GJ. Obstructive sleep apnoea syndrome: underestimated and undertreated. Brit Med Bull. 2004;72:49–64.PubMedCrossRefGoogle Scholar
  29. 29.
    Strobel RJ, Rosen RC. Obesity and weight loss in obstructive sleep apnea: a critical review. Sleep. 1996;19:104–115.PubMedGoogle Scholar
  30. 30.
    Fletcher EC. Shah Anjana, Qian W, Miller CC: “Near miss” death in obstructive sleep apnea: a critical care syndrome. Crit Care Med. 1991;19:1158–1164.PubMedCrossRefGoogle Scholar
  31. 31.
    Adams JP, Murphy PG. Obesity and anesthesia and intensive care. Br J Anaesth. 2000;85:91–108.PubMedCrossRefGoogle Scholar
  32. 32.
    The Report of the American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definitions and measurement techniques in clinical research. Sleep. 1999;22:677–689.Google Scholar
  33. 33.
    Knill RL, Moote CA, Skinner MI, et al. Anesthesia with abdominal surgery leads to intense REM sleep during the first postoperative week. Anesthesiology. 1990;73:52–61.PubMedCrossRefGoogle Scholar
  34. 34.
    Livingston EH, Huerta S, Arthur D, et al. Male gender is a predictor for morbidity and age a predictor of mortality for patients undergoing bypass surgery. Ann Surg. 2002;236:576–582.PubMedCrossRefGoogle Scholar
  35. 35.
    Byhahn C, Lischke V, Meninger D, et al. Peri-operative complications during percutaneous tracheostomy in obese patients. Anaesthesia. 2005;60:12–15.PubMedCrossRefGoogle Scholar
  36. 36.
    Frey WC, Pilcher J. Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery. Obes Surg. 2003;13:676–683.PubMedCrossRefGoogle Scholar
  37. 37.
    Shenkman Z, Shir Y, Brodsky JB. Perioperative management of the obese patient. Br J Anaesth. 1993;70:349–359.PubMedCrossRefGoogle Scholar
  38. 38.
    Vaughan RW, Bauer S, Wise L. Volume and pH of gastric juice in obese patients. Anesthesiology. 1975;43:686–689.PubMedCrossRefGoogle Scholar
  39. 39.
    Roberts RB, Shirley MA. Reducing the risk of acid aspiration during cesarean section. Anesth Analg. 1974;53:859–868.PubMedCrossRefGoogle Scholar
  40. 40.
    Zacchi P, Mearin F, Humbert P, et al. Effect of obesity on gastroesophageal resistance to flow in man. Dig Dis Sci. 1991;36:1473–1480.PubMedCrossRefGoogle Scholar
  41. 41.
    Vila P, Valles CJ, Canet J, et al. Acid aspiration in morbidly obese patients: famotidine vs. ranitidine. Anaesthesia. 1991;46:967–969.PubMedCrossRefGoogle Scholar
  42. 42.
    Ebert TJ, Shankar H, Haake RM. Perioperative considerations for patients with morbid obesity. Anesthesiol Clin. 2006;24:621–636.PubMedCrossRefGoogle Scholar
  43. 43.
    El-Solh AA. Clinical approach to the critically ill, morbidly obese patient. Am J Respir Crit Care Med. 2004;169:557–561.PubMedCrossRefGoogle Scholar
  44. 44.
    Pelosi P, Ravagnan I, Giurati G, et al. Positive end-expiratory pressure improves respiratory function in obese but not in normal subjects during anesthesia and paralysis. Anesthesiology. 1999;91:1221–1231.PubMedCrossRefGoogle Scholar
  45. 45.
    Burns SM, Egloff MB, Ryan B, et al. Effect of body position on spontaneous respiratory rate and tidal volume in patients with obesity, abdominal distention and ascites. Am J Crit Care. 1994;3:102–106.PubMedGoogle Scholar
  46. 46.
    Poulose BK, Griffen MR, Zhu Y, et al. National analysis of adverse patient safety events in bariatric surgery. Am Surg. 2005;71:406–413.PubMedGoogle Scholar
  47. 47.
    McLear PW, Thawley SE. Airway management in obesity hypoventilation syndrome. Clin Chest Med. 1991;12:585–588.PubMedGoogle Scholar
  48. 48.
    Headley WB, Rodning CB. Fabricated single lumen tracheal ­cannula for a morbidly obese patient. J Otolaryngol. 1993;22:438–441.PubMedGoogle Scholar
  49. 49.
    Mansharamani NG, Koziel H, Garland R, et al. Safety of bedside percutaneous dilatational tracheostomy in obese patients in the ICU. Chest. 2000;117:1426–1429.PubMedCrossRefGoogle Scholar
  50. 50.
    El-Solh A, Sikka P, Bozkanat E, et al. Morbid obesity in the medical ICU. Chest. 2001;120:1989–1997.PubMedCrossRefGoogle Scholar
  51. 51.
    Pasulka PS, Bistrian BR, Benotti PN, Blackburn GL. The risks of surgery in obese patients. Ann Intern Med. 1986;104:540–546.PubMedCrossRefGoogle Scholar
  52. 52.
    Rose DK, Cohen MM, Wigglesworth DF, DeBoer DP. Critical respiratory events in the postanethesia care unit. Anesthesiology. 1994;81:410–418.PubMedCrossRefGoogle Scholar
  53. 53.
    Davidson JE, Callery C. Care of the obese patient requiring intermediate-level care or intensive care. Obes Surg. 2001;11:93–97.PubMedCrossRefGoogle Scholar
  54. 54.
    Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968–977.PubMedCrossRefGoogle Scholar
  55. 55.
    Alexander JK. The cardiomyopathy of obesity. Prog Cardiovasc Dis. 1985;27:325–333.PubMedCrossRefGoogle Scholar
  56. 56.
    Berklap B, Cesur V, Corapcioglu D, et al. Obesity and left ventricular diastolic dysfunction. Int J Cardiol. 1995;52:23–26.CrossRefGoogle Scholar
  57. 57.
    Reisen E, Frohlich ED, Messerli FN, et al. Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med. 1983;98:315–319.CrossRefGoogle Scholar
  58. 58.
    Messerli FH. Cardiovascular effects of obesity and hypertension. Lancet. 1982;1:1165–1168.PubMedCrossRefGoogle Scholar
  59. 59.
    Merlino G, Scaglione R, Carrao S, et al. Association between reduced lymphocyte beta-adrenergic receptors and left ventricular dysfunction in young obese subjects. Int J Obes Metab Disord. 1994;18:699–703.Google Scholar
  60. 60.
    Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med. 1996;335:13–20.CrossRefGoogle Scholar
  61. 61.
    Merlino G, Scaglione R, Paterna S, et al. Lymphocyte beta-adrenergic receptors in young subjects with peripheral or central obesity: relationship with central haemodynamics and left ventricular function. Eur Heart J. 1994;15:786–792.PubMedGoogle Scholar
  62. 62.
    Nguyen NT, Wolfe BM. The physiologic effects of pneumoperitoneum in the morbidly obese. Ann Surg. 2005;241:219–226.PubMedCrossRefGoogle Scholar
  63. 63.
    Nguyen NT, Ho HS, Fleming NW, et al. Cardaic function during laparoscopic vs. open gastric bypass: a randomized comparison. Surg Endosc. 2002;16:78–83.PubMedCrossRefGoogle Scholar
  64. 64.
    Azevedo A, Ramos E, von Hafe P, Barros H. Upper-body adiposity and risk of myocardial infarction. J Cardiovasc Risk. 1999;6:321–325.PubMedGoogle Scholar
  65. 65.
    Bray GA. Pathophysiology of obesity. Am J Clin Nutr. 1992;55:488S–494S.PubMedGoogle Scholar
  66. 66.
    Jeevanandam M, Young DH, Schiller WR. Obesity and the metabolic response to severe trauma in man. J Clin Invest. 1991;87:262–269.PubMedCrossRefGoogle Scholar
  67. 67.
    Ireton-Jones CS, Francis C. Obesity: nutrition support and practice and application to critical care. Nutr Clin Pract. 1995;10:144–149.PubMedCrossRefGoogle Scholar
  68. 68.
    Levi D, Goodman ER, Patel M, Savransky Y. Critical care of the obese and bariatric surgical patient. Crit Care Clin. 2003;19:11–32.PubMedCrossRefGoogle Scholar
  69. 69.
    Marik P, Varon J. The obese patient in the ICU. Chest. 1998;113:492–498.PubMedCrossRefGoogle Scholar
  70. 70.
    Dickerson RN, Boschert KJ, Kudsk KA, Brown RO. Hypocaloric enteral tube feeding in critically ill obese patients. Nutrition. 2002;18:241–246.PubMedCrossRefGoogle Scholar
  71. 71.
    The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. N Engl J Med. 1991;325:525–532.CrossRefGoogle Scholar
  72. 72.
    Heyland DK, MacDonald S, Keefe L, Drover JW. Total parenteral nutrition in the critically ill patient. JAMA. 1998;280:2013–2019.PubMedCrossRefGoogle Scholar
  73. 73.
    Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–1367.PubMedCrossRefGoogle Scholar
  74. 74.
    Pieracci FM, Hydo LJ, Eachempati SR, et al. Higher body mass index predicts need for insulin but neither hyperglycemia, nosocomial infection, nor mortality of critically ill surgical patients. Surg Infect. 2008;9(2):121–130.CrossRefGoogle Scholar
  75. 75.
    Salazar DE, Corcoran GB. Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med. 1988;84:1053–1060.PubMedCrossRefGoogle Scholar
  76. 76.
    Stockholm KH, Brochner-Mortensen J, Hoilund-Carlson PF. Increased glomerular filtration rate and adrenocortical function in obese women. Int J Obes. 1980;4:57–63.Google Scholar
  77. 77.
    Snider RD, Kruse JA, Bander JJ, Dunn GH. Accuracy of estimated creatinine clearance in obese patients with stable renal function in the intensive care unit. Pharmacotherapy. 1995;15:747–753.PubMedGoogle Scholar
  78. 78.
    Baile GR, Cockshott ID, Douglas EJ, et al. Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patients. Br J Anaesth. 1992;68:486–491.CrossRefGoogle Scholar
  79. 79.
    Trempy GA, Rock P. Anesthetic management of a morbidly obese woman with a massive ovarian cyst. J Clin Anesth. 1993;5:62–68.PubMedCrossRefGoogle Scholar
  80. 80.
    Morgan DJ, Bray KM. Lean body mass as a predictor of drug dosage. Implications for drug therapy. Clin Pharmacokinet. 1994;26:292–307.PubMedCrossRefGoogle Scholar
  81. 81.
    Abernethy DR, Greenblatt DJ. Pharmacokinetics of drugs in obesity. Clin Pharmacokinet. 1982;7:108–124.PubMedCrossRefGoogle Scholar
  82. 82.
    Naeye RL, Roode P. The size and numbers of cells in visceral organs in human obesity. Am J Clin Path. 1970;54:251–253.PubMedGoogle Scholar
  83. 83.
    Cheymol G. Clinical pharmacokinetics of drugs in obesity: an update. Clin Pharmacokinet. 1993;25:103–114.PubMedCrossRefGoogle Scholar
  84. 84.
    Yee JY, Duffell SB. The effect of body weight on dalteparin pharmacokinetics. Eur J Clin Pharm. 2000;56:293–297.CrossRefGoogle Scholar
  85. 85.
    Nasraway SA. Use of sedative medications in the intensive care unit. Semin Respir Crit Care Med. 2001;22:165–174.PubMedCrossRefGoogle Scholar
  86. 86.
    Servin F, Farinotti R, Haberer JP, Desmonts JM. Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide: a clinical and pharmacokinetic study. Anesthesia. 1993;78:657–665.CrossRefGoogle Scholar
  87. 87.
    Greenblatt DJ, Abernethy DR, Locniskar A, et al. Effect of age, gender, and obesity on midazolam kinetics. Anesthesia. 1984;61:27–35.Google Scholar
  88. 88.
    Casati A, Putzu M. Anesthesia in the obese patient: pharmacokinetic considerations. J Clin Anesth. 2005;17:134–145.PubMedCrossRefGoogle Scholar
  89. 89.
    Kress JP, Pohlman AS, O’Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342:1471–1477.PubMedCrossRefGoogle Scholar
  90. 90.
    Shapiro BA, Warren J, Egol AB, et al. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine. Crit Care Med. 1995;23:1596–1600.PubMedCrossRefGoogle Scholar
  91. 91.
    Shibutani K, Inchiosa MA, Sawada K, et al. Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients. Br J Anaesth. 2005;93:377–383.CrossRefGoogle Scholar
  92. 92.
    Bauer LA, Black DJ, Lill JS. Vancomycin dosing in morbidly obese patients. Eur J Clin Pharmacol. 1998;54:621–625.PubMedCrossRefGoogle Scholar
  93. 93.
    Blouin RA, Bauer LA, Miller DD, et al. Vancomycin pharmacokinetics in normal and morbidly obese subjects. Antimicrob Agents Chemother. 1982;21:575–580.PubMedCrossRefGoogle Scholar
  94. 94.
    Beardon DT, Rodvold KA. Dosing adjustment for antibacterials in obese patients: applying clinical pharmacokinetics. Clin Pharmacokinet. 2000;38:415–426.CrossRefGoogle Scholar
  95. 95.
    Stalker DJ, Jingbluth GL, Hopkins NK, Batts DH. Pharmacokinetics and tolerance of single and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers. J Antimicrob Chemother. 2003;51:1239–1246.PubMedCrossRefGoogle Scholar
  96. 96.
    Kutscha-Lissberg F, Helber U, Muhr G, Koller M. Linezolid penetration into bone and joint tissues infected with methicillin-resistance staphylococci. Antimicrob Agents Chemother. 2003;47:3964–3966.PubMedCrossRefGoogle Scholar
  97. 97.
    Stein GE, Schooley SL, Peloquin CA, et al. Pharmacokinetics and pharmacodynamics of linezolid in obese patient with cellulitis. Ann Pharmacother. 2005;39:427–432.PubMedCrossRefGoogle Scholar
  98. 98.
    Mersfelder TL, Smith CL. Linezolid pharmacokinetics in an obese patient. Am J Health Syst Pharm. 2005;62:464–467.PubMedGoogle Scholar
  99. 99.
    Traynor AM, Nafziger AN, Bertino JS. Aminoglycoside dosing weight correction factors for patients of various body sizes. Antimicrob Agents Chemother. 1995;39:545–548.PubMedCrossRefGoogle Scholar
  100. 100.
    Allard S, Kinzig M, Bovin G, et al. Intravenous ciprofloxacin disposition in obesity. Clin Pharmacol Ther. 1993;54:368–373.PubMedCrossRefGoogle Scholar
  101. 101.
    Bauer LA, Edwards WAD, Dellinger EP, Simonowitz DA. Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients. Eur J Clin Pharmacol. 1983;24:643–647.PubMedCrossRefGoogle Scholar
  102. 102.
    Blouin RA, Brouwer KL, Record KE, et al. Amikacin pharmacokinetics in morbidly obese patients undergoing gastric-bypass surgery. Clin Pharmacokinet. 1985;4:70–72.Google Scholar
  103. 103.
    Korsager S. Administration of gentamicin to obese patients. Int J Clin Pharmacol Ther Toxicol. 1980;18:549–553.PubMedGoogle Scholar
  104. 104.
    Corcoran GB, Salazar DE, Scgentag JJ. Excessive aminoglycoside nephrotoxicity in obese patients. Am J Med. 1988;85:279.PubMedCrossRefGoogle Scholar
  105. 105.
    Corcoran GB, Salazar DE. Obesity as a risk factor in drug-induced organ injury. IV. Increased gentamicin nephrotoxicity in the obese overfed rat. J Pharmacol Exp Ther. 1989;248:17–22.PubMedGoogle Scholar
  106. 106.
    Wurtz R, Itokazu G, Rodvold K. Antimicrobial dosing in obese patients. Clin Infect Dis. 1997;25:112–118.PubMedCrossRefGoogle Scholar
  107. 107.
    Bernard GR, Vincent J, Laterre P, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. New Engl J Med. 2001;344:699–709.PubMedCrossRefGoogle Scholar
  108. 108.
    Levy H, Small D, Heiselman DE, et al. Obesity does not alter the pharmacokinetics of drotrecogin alfa (activated) in severe sepsis. Ann Pharmacother. 2005;39:262–267.PubMedCrossRefGoogle Scholar
  109. 109.
    Batist G, Bothe A, Bern M, et al. Low antithrombin III in morbid obesity: return to normal with weight reduction. JPEN J Parenter Enteral Nutr. 1983;7:447–449.PubMedCrossRefGoogle Scholar
  110. 110.
    Merli GJ. Prophylaxis for deep venous thrombosis and pulmonary embolism in the surgical patient. Clin Cornerstone. 2000;2:15–28.PubMedCrossRefGoogle Scholar
  111. 111.
    Clayton JK, Anderson JR, McNicol GP. Preoperative prediction of postoperative deep venous thrombosis. BMJ. 1976;2:910–912.PubMedCrossRefGoogle Scholar
  112. 112.
    Kakkar VV, Howe CT, Nicolaides AN, et al. Deep vein thrombosis of the leg: is there a “high risk” group?. Am J Surg. 1970;120:527–530.PubMedCrossRefGoogle Scholar
  113. 113.
    Lowe GD, McArdle BM, Carter DC, et al. Prediction and selective prophylaxis of venous thrombus in elective gastrointestinal surgery. Lancet. 1982;1:409–412.PubMedCrossRefGoogle Scholar
  114. 114.
    Blaszyk H, Wollan PC, Witkiewicz AK, et al. Death from pulmonary thromboembolism is Severe Obesity: lack of association with established genetic and clinical risk factors. Virchows Arch. 1999;434:529–532.PubMedCrossRefGoogle Scholar
  115. 115.
    Blaszyk H, Bjornsson J. Factor V Leiden and morbid obesity in fatal postoperative pulmonary embolism. Arch Surg. 2000;135:1410–1413.PubMedCrossRefGoogle Scholar
  116. 116.
    Westling A, Bergqvist D, Bostrom A, et al. Incidence of deep venous thrombosis in patients undergoing obesity surgery. World J Surg. 2002;26:470–473.PubMedCrossRefGoogle Scholar
  117. 117.
    Printen KJ, Miller EV, Mason EE, et al. Venous thromboembolism in the morbidly obese. Surg Gynecol Obstet. 1978;147:63–64.PubMedGoogle Scholar
  118. 118.
    Erikkson S, Backman L, Ljungstrom KG. The incidence of clinical postoperative thrombosis after gastric surgery for obesity during 16 years. Obes Surg. 1997;7:332–335.CrossRefGoogle Scholar
  119. 119.
    Gonzalez QH, Tishler DS, Plata-Munoz JJ, et al. Incidence of clinically significant deep venous thrombosis after laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2004;18:1082–1084.PubMedGoogle Scholar
  120. 120.
    Podnos YD, Jimenez JC, Wilson SE, et al. Complications after laparoscopic gastric bypass. Arch Surg. 2003;138:957–961.PubMedCrossRefGoogle Scholar
  121. 121.
    Fernandez AZ, Demaria EJ, Tichansky DS, et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg. 2004;239:698–703.PubMedCrossRefGoogle Scholar
  122. 122.
    Mason EE, Renquist KE, Jiang D. Perioperative risks and safety of surgery for severe obesity. Am J Clin Nutr. 1992;55:573S–576S.PubMedGoogle Scholar
  123. 123.
    Prystowsky JB, Morasch MD, Eskandari MK, et al. Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients. Surgery. 2005;138:759–763.PubMedCrossRefGoogle Scholar
  124. 124.
    Gonzalez R, Haines K, Nelson LG, et al. Predictive factors of thromboembolic events in patients undergoing Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2:30–35.PubMedCrossRefGoogle Scholar
  125. 125.
    Mason EE, Renuist KE, Huang YH, et al. Causes of 30-day bariatric surgery mortality: with an emphasis on bypass obstruction. Obes Surg. 2007;17:9–14.PubMedCrossRefGoogle Scholar
  126. 126.
    Wu EC, Barba CA. Current practices in the prophylaxis of venous thromboembolism in bariatric surgery. Obes Surg. 2000;10:7–14.PubMedCrossRefGoogle Scholar
  127. 127.
    Scholton DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg. 2002;12:19–24.CrossRefGoogle Scholar
  128. 128.
    Gerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119:132S–175S.CrossRefGoogle Scholar
  129. 129.
    Sugerman HJ, Sugerman EL, Wolke L, et al. Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Ann Surg. 2001;234:41–46.PubMedCrossRefGoogle Scholar
  130. 130.
    Sapala JA, Wood MH, Schuhknecht MP, Sapala A. Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg. 2003;13:819–825.PubMedCrossRefGoogle Scholar
  131. 131.
    Piano G, Ketteler ER, Prachand V, et al. Safety, feasibility, and outcome of retrievable vena cava filters in high-risk surgical patients. J Vasc Surg. 2007;45:784–788.PubMedCrossRefGoogle Scholar
  132. 132.
    Lee S, Carmody B, Wolfe L, et al. Effect of location and speed of diagnosis on anastomotic leak outcomes in 3828 bypass cases. J Gastrointest Surg. 2007;11(6):708–713.PubMedCrossRefGoogle Scholar
  133. 133.
    Hamilton EC, Sims TL, Hamilton TT, et al. Clinical predictors of leak after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Surg Endosc. 2003;17:679–684.PubMedCrossRefGoogle Scholar
  134. 134.
    Lee SD, Khouzam MN, Kellum JM, et al. Selective, versus routine, upper gastrointestinal series leads to equal morbidity and reduced hospital stay in laparoscopic gastric bypass patients. Surg Obes Relat Dis. 2007;3:413–416.PubMedCrossRefGoogle Scholar
  135. 135.
    Doraiswamy A, Rasmussen JJ, Pierce J, et al. The utility of routine postoperative upper GI series following laparoscopic gastric bypass. Surg Endosc. 2007;21:2159–2162.PubMedCrossRefGoogle Scholar
  136. 136.
    Hwang RF, Swartz DE, Felix EL. Causes of small bowel obstruction after laparoscopic gastric bypass. Surg Endosc. 2004;18:1631–1635.PubMedGoogle Scholar
  137. 137.
    Champion JK, Williams M. Small bowel obstruction and internal hernias after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003;13:596–600.PubMedCrossRefGoogle Scholar
  138. 138.
    Felsher J, Brodsky J, Brody F. Small bowel obstruction after laparoscopic Roux-en-Y gastric bypass. Surgery. 2003;134:501–505.PubMedCrossRefGoogle Scholar
  139. 139.
    Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–529.PubMedCrossRefGoogle Scholar
  140. 140.
    Keyser EJ, Ahmed NA, Mott BD, Tchervenkov J. Double closed loop obstruction and perforation in a previous Rouex-en-Y gastric bypass. Obes Surg. 1998;8:475–479.PubMedCrossRefGoogle Scholar
  141. 141.
    Fleser PS, Villalba M. Afferent limb volvulus and perforation of the bypassed stomach as a complication of Roux-en-Y gastric bypass. Obes Surg. 2003;13:453–456.PubMedCrossRefGoogle Scholar
  142. 142.
    Bertrand M, Godet G, Fléron M, et al. Lumbar muscle rhabdomyolysis after abdominal aortic surgery. Anesth Analg. 1997;85:11–15.PubMedGoogle Scholar
  143. 143.
    Tuckey J. Bilateral compartment syndrome complicating prolonged lithotomy position. Br J Anaesth. 1996;77:546–549.PubMedCrossRefGoogle Scholar
  144. 144.
    Bildsten SA, Dmochowski RR, Spindel MR, Auman JR. The risk of rhabdomyolysis and acute renal failure with the patient in the exaggerated lithotomy position. J Urol. 1994;152:1970–1972.PubMedGoogle Scholar
  145. 145.
    Guzzi LM, Mills LA, Greenman P. Rhabdomyolysis, acute renal failure, and the exaggerated lithotomy position. Anesth Analg. 1993;77:635–637.PubMedCrossRefGoogle Scholar
  146. 146.
    Gorecki PJ, Cottam D, Ger R, et al. Lower extremity compartment syndrome following a laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2002;12:289–291.PubMedCrossRefGoogle Scholar
  147. 147.
    Bostanjian D, Anthone GJ, Hamoui N, Crookes PF. Rhabdomyolysis of gluteal muscles leading to renal failure: a potentially fatal complication of surgery in the morbidly obese. Obes Surg. 2003;13:302–305.PubMedCrossRefGoogle Scholar
  148. 148.
    Wiltshire JP, Custer T. Lumbar muscle rhabdomyolysis as a cause of acute renal failure after roux-en-Y gastric bypass. Obes Surg. 2003;13:306–313.PubMedCrossRefGoogle Scholar
  149. 149.
    Torres-Villalobos G, Kimura E, Mosqueda JL, et al. Pressure-induced rhabdomyolysis after bariatric surgery. Obes Surg. 2003;13:297–301.PubMedCrossRefGoogle Scholar
  150. 150.
    Miyamoto T, Ikehar A, Kobayashi T, et al. Cutaneous eruptions in coma patients with nontraumatic rhabdomyolysis. Dermatology. 2001;203:233–237.PubMedCrossRefGoogle Scholar
  151. 151.
    Zager RA, Bredi C. The influence of mannitol on myoglobinuric acute renal failure: functional, biochemical, and morphological assessments. J Am Soc Nephrol. 1991;2:848–855.PubMedGoogle Scholar
  152. 152.
    Abassi ZA, Hoffman A, Better OS. Acute renal failure complicating muscle crush injury. Semin Nephrol. 1998;18:558–565.PubMedGoogle Scholar
  153. 153.
    Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol. 2000;11:1553–1561.PubMedGoogle Scholar
  154. 154.
    Ward MM. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med. 1988;148:1553–1557.PubMedCrossRefGoogle Scholar
  155. 155.
    Marik PE. The paradoxical effect of obesity on outcomes in critically ill patients. Crit Care Med. 2006;34:1251–1253.PubMedCrossRefGoogle Scholar
  156. 156.
    Frat JP. Obesity in ICU patients: increase or decrease in mortality? Chest. 2005;127:414.PubMedCrossRefGoogle Scholar
  157. 157.
    Leichman JG, Taegtmeyer H. The fat ones fare well- but is it fair to compare? Crit Care Med. 2006;34:3042–3043.PubMedCrossRefGoogle Scholar
  158. 158.
    Rice TW. Obesity and acute lung injury: the “weight” is over. Chest. 2007;131:333–334.PubMedCrossRefGoogle Scholar
  159. 159.
    Aldawood A, Arabi Y, Dabbagh O. Association of obesity with increased mortality in the critically ill patient. Anaesth Intensive Care. 2006;34:629–633.PubMedGoogle Scholar
  160. 160.
    Finkielman J, Gajic O, Afessa B. Underweight is independently associated with mortality in post-operative and non-operative patients admitted to the intensive care unit: a retrospective study. BMC Emerg Med. 2004;4:3–9.PubMedCrossRefGoogle Scholar
  161. 161.
    Morris AE, Stapleton RD, Rubenfeld GD, Hudson LD, Caldwell E, Steinberg KP. The association between body mass index and clinical outcomes in acute lung injury. Chest. 2007;131:342–348.PubMedCrossRefGoogle Scholar
  162. 162.
    Ray DE, Matchett SC, Baker K, Wasser T, Young MJ. The effect of body mass index on patient outcomes in a medical ICU. Chest. 2005;127:2125–2131.PubMedCrossRefGoogle Scholar
  163. 163.
    Tremblay A, Bandi V. Impact of body mass index on outcomes following critical care. Chest. 2003;123:1202–1207.PubMedCrossRefGoogle Scholar
  164. 164.
    Brown CV, Neville AL, Rhee P, Salim A, Velmahos GC, Demetriades D. The impact of obesity on the outcomes of 1, 153 critically injured blunt trauma patients. J Trauma. 2005;59:1048–1051.PubMedCrossRefGoogle Scholar
  165. 165.
    Bochicchio GV, Joshi M, Bochicchio K, Nehman S, Tracy JK, Scalea TM. Impact of obesity in the critically ill trauma patient: a prospective study. J Am Coll Surg. 2006;203:533–538.PubMedCrossRefGoogle Scholar
  166. 166.
    Bercault N, Boulain T, Kuteifan K, Wolf M, Runge I, Fleury JC. Obesity-related excess mortality rate in an adult intensive care unit: a risk-adjusted matched cohort study. Crit Care Med. 2004;32:998–1003.PubMedCrossRefGoogle Scholar
  167. 167.
    Pieracci FM, Hydo LJ, Pomp A, et al. The relationship between body mass index and postoperative mortality from critical illness. Obes Surg. 2008;18(5):501–507.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Fredric M. Pieracci
    • 1
  • Alfons Pomp
    • 2
  • Philip S. Barie
    • 3
  1. 1.Department of Surgery and Public HealthWeill Cornell Medical CenterNew YorkUSA
  2. 2.Department of SurgeryWeill Cornell Medical CollegeNew YorkUSA
  3. 3.Department of Surgery and Public HealthWeill Cornell Medical CenterNew YorkUSA

Personalised recommendations